paramyxoviru
infect
detect
worldwid
emerg
zoonot
virus
current
specif
therapeut
treatment
vaccin
avail
mani
diseas
recent
studi
demonstr
peptid
deriv
two
heptad
repeat
region
paramyxoviru
fusion
protein
could
use
inhibitor
viru
fusion
mechan
underli
activ
accord
class
viru
fusion
protein
human
immunodefici
viru
hiv
influenza
viru
fusion
protein
member
class
viru
fusion
protein
fragment
bind
form
sixhelix
bundl
three
fragment
form
central
coil
bundl
surround
three
coil
fragment
post
fusion
conform
state
fusion
core
hypothes
introduc
exogen
compet
endogen
counterpart
result
fusion
inhibit
use
newcastl
diseas
viru
ndv
model
design
sever
protein
inhibitor
denot
well
could
bind
region
fusion
protein
respect
protein
express
purifi
use
gstfusion
express
system
escherichia
coli
protein
bind
peptid
vitro
display
inhibitori
activ
ndvmediat
cell
fusion
protein
bind
peptid
vitro
inhibit
viru
fusion
avirul
ndv
strain
ad
cleavag
fusion
protein
result
show
design
protein
could
serv
specif
antivir
agent
data
provid
addit
insight
differ
virul
avirul
strain
ndv
q
publish
elsevi
ltd
like
mani
envelop
virus
paramyxoviru
requir
viruscel
fusion
mediat
cellcel
fusion
least
two
viral
membran
glycoprotein
paramyxoviru
fusion
protein
f
attach
protein
hn
h
g
depend
genu
particip
fusion
process
mani
paramyxovirus
newcastl
diseas
viru
ndv
attach
protein
hn
ndv
absolut
requir
f
proteinmedi
cell
fusion
paramyxovirus
simian
parainfluenza
viru
respiratori
syncyti
viru
rsv
fusion
absolut
requir
attach
protein
mechan
underli
differ
unclear
f
protein
paramyxoviru
contain
conserv
function
domain
includ
fusion
peptid
two
heptad
repeat
hr
region
call
hra
hrb
fusion
peptid
respons
insert
f
protein
host
cell
membran
locat
immedi
region
paramyxoviru
biochem
crystal
structur
studi
demonstr
could
form
stabl
sixhelix
bundl
refer
trimer
heterodim
trimer
hairpin
suggest
repres
core
structur
postfus
f
protein
known
also
fusion
core
shown
peptid
deriv
hr
region
could
inhibit
virusmedi
cell
fusion
probabl
disturb
interact
hr
region
conform
chang
f
protein
like
member
paramyxovirida
famili
ndv
f
protein
synthes
initi
precursor
f
cleav
disulfidelink
subunit
f
f
furinlik
enzym
host
cell
cleavag
f
protein
necessari
protein
matur
fusion
activ
cleavabl
f
protein
key
determin
infect
pathogen
ndv
avirul
ndv
strain
f
protein
cleav
furinlik
enzym
cell
cultur
exist
f
cell
surfac
therefor
fusion
process
fulfil
unless
exogen
proteas
trypsin
ad
promot
f
cleavag
fusion
activ
form
previou
studi
laboratori
other
shown
similar
peptid
protein
peptid
deriv
ndv
f
protein
region
could
use
inhibitor
f
virusmedi
cell
fusion
inhibit
activ
peptid
poorli
character
like
due
hydrophob
peptid
protein
interestingli
previou
studi
show
peptid
deriv
domain
ndv
f
could
inhibit
f
proteinmedi
fusion
ad
prior
cleavag
f
protein
vitro
transfect
system
howev
mechan
involv
unclear
previou
studi
show
free
glutathionestransferas
gst
fusion
could
block
fusion
process
mediat
ndv
virul
strain
one
possibl
neg
result
could
due
instabl
aggreg
vitro
prepar
rather
differ
virul
avirul
strain
therefor
requir
experiment
stabl
prepar
distinguish
possibl
order
better
character
ndv
fusion
mechan
studi
built
upon
previou
construct
design
three
new
protein
call
protein
plu
ss
repres
disulfid
bond
f
f
protein
b
schemat
construct
produc
sequenti
link
two
linker
sggrgg
ggsgg
obtain
link
two
amino
acid
linker
sggrgg
ggsgg
shown
anoth
c
terminu
anoth
n
terminu
protein
lack
one
c
terminu
construct
predict
stabl
free
peptid
base
format
sixhelix
bundl
time
serv
also
inhibitor
base
current
conform
chang
model
lack
one
free
hr
domain
biochem
charact
design
protein
analyz
fusion
inhibit
activ
determin
use
ndv
virul
avirul
strain
mediat
cell
fusion
model
probabl
mechan
fusion
inhibit
discuss
shown
figur
two
heptadrepeat
region
determin
studi
design
protein
engin
basi
previou
studi
shown
figur
b
similar
lack
one
c
terminu
modifi
addit
c
terminu
one
n
terminu
gene
design
protein
prepar
standard
pcr
method
clone
gst
fusion
express
vector
see
materi
method
design
protein
solubl
could
bind
respect
peptid
vitro
gst
fusion
express
solubl
protein
escherichia
coli
could
separ
easili
gst
affin
column
gst
fusion
protein
solubl
supernat
lyse
e
coli
cell
express
protein
solubl
express
elut
protein
mm
nacl
ad
elut
buffer
increas
elut
volum
use
order
improv
result
like
due
hydrophob
region
purifi
remov
cleav
gst
figur
gst
pulldown
assay
show
could
bind
especi
well
show
convinc
bind
figur
could
bind
peptid
figur
c
demonstr
gelfiltr
analysi
gst
untag
could
interact
peptid
respect
mix
peptid
elut
peak
shift
compar
control
furthermor
sdspage
analysi
demonstr
associ
protein
peptid
figur
indic
specif
interact
peptid
partner
result
suggest
design
protein
could
potenti
fusion
inhibitor
ndv
f
proteinmedi
cell
fusion
order
determin
actual
molecular
mass
assembl
charact
protein
gelfiltr
chemic
crosslink
analysi
use
describ
materi
method
gelfiltr
assay
elut
peak
protein
peak
posit
correspond
kda
figur
b
c
wherea
calcul
molecular
mass
kda
kda
respect
indic
could
form
multim
probabl
trimer
subsequ
chemic
crosslink
prepar
show
dimer
trimer
could
seen
reduc
gel
figur
b
monomersdim
tend
fade
eg
crosslink
concentr
increas
wherea
trimer
band
becam
promin
data
implic
protein
trimer
although
monomerdim
band
still
visibl
even
high
concentr
crosslink
also
demonstr
gelfiltr
peak
shift
one
trimer
probabl
could
bind
three
molecul
figur
b
c
design
protein
ahel
thermost
cd
spectra
design
protein
display
characterist
signatur
ahel
protein
minima
nm
nm
figur
c
thermodynam
stabil
analysi
demonstr
protein
thermost
pb
buffer
figur
e
g
h
even
pb
contain
guhcl
figur
e
accord
melt
temperatur
figur
f
respect
protein
almost
stabl
protein
stabl
among
three
design
protein
consist
highest
solubl
result
show
design
protein
retain
characterist
protein
describ
gelfiltr
chromatographi
inset
protein
peak
run
tristricin
sdspage
indic
interact
elut
curv
show
peak
shift
bind
peptid
b
protein
mixtur
peptid
subject
superdex
gelfiltr
chromatographi
inset
protein
peak
run
tristricin
sdspage
indic
interact
elut
curv
show
peak
shift
bind
peptid
c
protein
mixtur
peptid
subject
superdex
gelfiltr
chromatographi
inset
protein
peak
run
tristricin
sdspage
indic
interact
elut
curv
show
peak
shift
bind
peptid
elut
peak
posit
standard
protein
kda
kda
run
column
shown
b
protein
elut
column
elut
volum
correspond
kda
kda
protein
standard
indic
protein
monom
protein
could
form
trimer
protein
molecular
mass
marker
shown
kda
sdspage
figur
note
none
protein
measur
absorb
nm
therefor
absorb
record
nm
protein
concentr
use
experi
mgml
prepar
stabl
either
singl
peptid
cd
result
provid
evid
specif
interact
peptid
addit
peptid
cd
spectra
increas
especi
nm
nm
figur
c
indic
increas
ahel
content
contrast
chang
cd
spectra
curv
mixtur
peptid
figur
b
result
demonstr
protein
could
interact
peptid
ahel
mode
investig
fusioninhibit
activ
design
protein
virusinduc
cell
fusion
plaqu
format
inhibit
assay
perform
describ
materi
method
shown
figur
protein
could
block
ndv
virul
strain
mediat
cell
fusion
plaqu
format
inhibit
activ
could
complet
inhibit
virusinduc
syncytia
plaqu
format
high
concentr
mm
figur
show
ic
mm
fusion
inhibit
assay
protein
sampl
ad
time
viru
adsorpt
ie
block
viru
infect
similar
result
obtain
ad
cultur
medium
infect
cell
result
indic
could
inhibitor
ndv
virul
strainmedi
cell
fusion
could
design
protein
could
inhibit
ndv
avirul
strainmedi
cell
fusion
ad
trypsin
digest
infect
cell
ndv
avirul
straininfect
cell
could
form
syncytia
figur
uncleav
f
protien
trypsin
digest
obviou
syncytia
observ
figur
b
determin
fusion
inhibit
activ
design
protein
ad
trypsin
digest
cell
fusion
inhibit
test
perform
describ
materi
method
result
show
design
protein
includ
could
inhibit
syncytia
format
ad
trypsin
digest
figur
c
b
ic
valu
mm
mm
mm
respect
howev
protein
lost
inhibit
activ
ad
trypsin
digest
similarli
protein
show
much
lower
inhibitori
activ
figur
b
b
result
show
could
interact
uncleav
f
protein
could
interact
matur
f
protein
could
interact
either
f
cleav
f
protein
ie
activ
form
f
f
complex
order
determin
protein
perform
inhibit
activ
protein
mix
differ
proport
determin
inhibit
figur
cd
spectra
thermal
stabil
measur
protein
protein
mgml
use
show
c
typic
ahelix
secondari
structur
e
g
h
thermal
stabil
pb
even
e
f
pb
contain
guhcl
f
protein
seem
stabl
protein
h
seem
slightli
stabl
g
protein
mix
mix
led
c
increas
ellipt
nm
nm
chang
b
mix
mix
indic
interact
thermal
denatur
curv
record
nm
scan
rate
deg
cmin
activ
ndv
virul
strainmedi
cell
fusion
found
inhibit
activ
neutral
mix
equal
molar
concentr
effect
decreas
reduct
concentr
figur
result
well
gst
pulldown
assay
figur
indic
protein
perform
fusion
inhibit
activ
bind
domain
f
protein
still
unclear
stage
occur
address
high
concentr
protein
ad
differ
time
adsorpt
ndv
virul
strain
hela
cell
strikingli
protein
could
inhibit
cell
fusion
earli
stage
viru
adsorpt
ie
min
figur
suggest
bound
f
protein
earli
stage
conform
chang
prevent
viru
entri
becom
new
therapeut
strategi
prevent
viru
infect
viru
fusion
inhibit
current
one
promis
approach
great
effort
made
elucid
molecular
mechan
envelop
viru
entri
fusion
increas
number
studi
show
envelop
virus
similar
fusion
process
therefor
similar
studi
fusion
inhibit
conduct
recent
year
peptid
deriv
heptad
repeat
region
viru
fusion
protein
demonstr
fusion
inhibitor
mani
envelop
virus
class
retroviru
paramyxoviru
hiv
peptid
call
enfuvirtid
q
deriv
cpeptid
domain
current
finish
third
clinic
trial
usa
antihiv
drug
howev
high
cost
peptid
synthesi
instabl
limit
broad
use
drug
studi
show
peptid
correspond
ntermin
heptad
repeat
npeptid
weak
inhibitor
hiv
fusion
like
due
tendenc
aggreg
much
effort
devot
design
stabl
effect
protein
inhibitor
hiv
fusion
includ
npeptid
fuse
trimer
coiledcoil
chimer
protein
term
n
ccg
protein
call
demonstr
prevent
hiv
fusion
studi
design
sever
protein
inhibitor
includ
basi
previou
studi
paramyxoviu
fusion
result
show
protein
could
inhibit
ndvmediat
cell
fusion
studi
show
also
protein
includ
stabl
could
obtain
easili
express
purif
design
strategi
test
envelop
virus
especi
hiv
paramyxoviru
viru
fusion
involv
least
two
envelop
glycoprotein
attach
protein
fusion
protein
respons
receptor
bind
cell
fusion
respect
f
protein
believ
mediat
fusion
cellular
membran
viru
membran
seri
conform
chang
current
model
least
three
conform
state
f
protein
ie
prefus
nativ
state
prehairpin
intermedi
state
postfus
state
postfus
state
two
conserv
hr
region
bind
antiparallel
fashion
coiledcoil
structur
form
socal
trimer
two
hr
region
highli
conserv
sequenc
paramyxovirus
like
hiv
mani
studi
includ
show
peptid
could
inhibit
virusmedi
f
proteinmedi
cell
fusion
mani
paramyxovirus
includ
ndv
howev
detail
inhibit
activ
peptid
clear
far
previou
studi
show
peptid
deriv
ndv
f
protein
fusion
inhibit
abil
ndvmediat
cell
fusion
studi
show
peptid
could
inhibit
f
proteinmedi
cell
fusion
ad
f
protein
cleav
like
hiv
peptid
paramyxoviru
fusion
protein
hydrophob
tend
aggreg
necessari
design
stabl
protein
inhibitor
function
previous
design
construct
call
construct
connect
singl
chain
result
show
protein
could
form
stabl
sixhelix
bundl
trimer
studi
basi
construct
anoth
ad
n
terminu
c
terminu
ie
form
two
new
construct
protein
construct
accord
recent
hiv
studi
demonstr
protein
ahel
thermost
similar
bind
charact
stabl
singl
peptid
characterist
fusion
plaqu
format
inhibit
test
show
could
inhibit
ndv
virul
strainmedi
cell
fusion
could
consist
result
previou
studi
indic
also
fusion
inhibit
mediat
bind
activ
peptid
suggest
might
inhibit
viru
fusion
interact
domain
intact
f
protein
design
protein
includ
could
inhibit
fusion
ndv
avirul
strain
ad
f
cleav
suggest
probabl
interact
correspond
domain
f
protein
cleav
f
f
complex
paramyxoviru
f
protein
synthes
initi
precursor
f
cleav
disulfidelink
f
f
furinlik
enzym
host
cell
f
protein
ndv
avirul
strain
furinlik
enzym
cleav
f
f
activ
promot
cell
fusion
addit
enzym
requir
cleav
f
protein
promot
infect
avirul
stain
use
system
conveni
detect
inhibit
activ
peptid
ad
f
cleavag
basi
result
peptid
correspond
domain
ndv
f
protein
inhibit
virusmedi
cell
fusion
inhibit
probabl
occur
differ
mechan
eg
differ
stage
f
protein
conform
chang
studi
show
could
inhibit
ndvmediat
cell
fusion
ad
f
cleavag
contrast
result
other
show
could
inhibit
cell
fusion
ad
prior
cleavag
activ
character
detect
inhibit
ad
differ
stage
viru
attach
result
show
could
exhibit
high
fusion
inhibit
ad
earli
min
viru
attach
almost
inhibit
detect
ad
min
attach
result
impli
conform
chang
f
protein
occur
quickli
receptor
bind
hn
protein
chang
irrevers
ie
could
interact
f
protein
earli
stage
fusion
may
explain
inhibit
activ
much
lower
ad
cleavag
activ
howev
result
still
consist
idea
peptid
could
interact
cleav
uncleav
f
protein
peptid
could
interact
f
protein
inhibit
viru
fusion
fusion
mediat
ndv
f
protein
absolut
requir
particip
hn
protein
paramyxovirus
rsv
previou
studi
shown
peptid
deriv
paramyxovirus
whose
fusion
absolut
requir
hn
protein
homologu
g
h
appear
fusion
inhibit
wherea
peptid
deriv
paramyxovirus
whose
fusion
absolut
requir
attach
protein
show
fusion
inhibit
effect
therefor
assum
interact
hn
f
protein
play
import
role
domain
exposur
conform
chang
f
protein
accept
conform
chang
f
protein
promot
hn
protein
bind
receptor
sever
studi
show
hn
protein
associ
f
protein
coexpress
hn
f
protein
alter
conform
cellsurfac
f
protein
addit
recent
report
demonstr
hn
protein
ndv
could
interact
domain
f
protein
indic
type
interact
may
affect
fusion
inhibit
peptid
accord
result
suppos
domain
matur
f
protein
hidden
interact
hn
protein
interact
continu
conform
chang
f
protein
may
reason
peptid
bind
block
fusion
howev
domain
immatur
f
protein
cover
hn
protein
expos
extern
peptid
addit
studi
requir
clarifi
detail
interact
hnf
along
associ
conform
chang
studi
provid
use
design
strategi
creation
viral
fusion
inhibitor
design
protein
may
serv
also
drug
target
vaccin
candid
especi
hiv
sever
viral
diseas
recent
studi
shown
coronaviru
like
employ
fusion
mechan
similar
envelop
virus
studi
sar
coronaviru
show
peptid
deriv
hr
region
spike
protein
could
also
inhibit
sar
viru
infect
vitro
indic
similar
design
strategi
may
yield
new
sar
coronaviru
fusion
inhibitor
well
studi
character
molecular
mechan
ndv
fusion
ndv
strain
virul
strain
kindli
provid
china
institut
veterinari
drug
control
ndv
strain
avirul
strain
kindli
provid
professor
zaishi
wang
china
institut
veterinari
drug
control
use
studi
hela
cell
obtain
american
type
cultur
collect
atcc
ndv
f
gene
clone
chines
virul
isol
gene
bank
access
region
use
deriv
amino
acid
residu
see
figur
three
differ
construct
made
pcr
shown
figur
construct
engin
link
two
amino
acid
linker
sggrgg
ggsgg
singlelett
amino
acid
abbrevi
use
construct
gener
sequenti
link
use
two
differ
linker
linker
sggrgg
linker
ggsgg
figur
b
construct
clone
bamh
xho
site
gst
fusion
express
vector
pharmacia
rhinoviru
proteas
cleavag
site
fusion
protein
commerci
prescission
proteas
cleavag
site
posit
plasmid
verifi
direct
dna
sequenc
e
coli
strain
transform
recombin
plasmid
grown
yta
medium
absorb
nm
induct
mm
iptg
h
express
bacteri
cell
harvest
lyse
sonic
pb
mm
sodium
phosphat
ph
mm
nacl
triton
ad
final
concentr
vv
lysat
incub
min
subsequ
clarifi
centrifug
g
min
clarifi
supernat
pass
glutathionesepharos
column
equalibr
pb
gst
fusion
proteinbound
column
wash
ten
column
volum
pb
elut
three
column
volum
mm
reduc
glutathion
extra
mm
nacl
ad
elut
fusion
protein
gst
fusion
protein
cleav
gstfusion
rhinoviru
proteas
kindli
provid
dr
k
hudson
j
heath
h
cleavag
buffer
mm
trishcl
ph
mm
nacl
mm
dtt
mm
edta
ph
free
gst
proteas
remov
passag
glutathionesepharos
column
result
protein
dialys
pb
concentr
ultrafiltr
store
protein
analyz
tristricin
page
sdspage
polyacrylamid
gel
protein
concentr
determin
bca
protein
determin
assay
pierc
biochem
gstor
free
protein
prepar
describ
gst
pulldown
assay
purifi
gst
fusion
protein
mix
purifi
min
glutathionesepharos
bead
ad
precipit
complex
contain
gst
fusion
protein
bead
wash
ten
column
volum
pb
elut
mm
reduc
glutathion
elut
sampl
run
tristricin
sdspage
purifi
protein
use
control
concentr
protein
prepar
use
experi
mgml
gst
columnpurifi
protein
purifi
gelfiltr
chromatographi
use
hiload
superdex
column
akta
fplc
system
pharmacia
gelfiltrationpurifi
mix
equimolar
peptid
separ
load
onto
hiload
superdex
column
gelfiltrationpurifi
mix
equimolar
peptid
load
onto
column
fraction
peak
collect
run
tristricin
sdspage
peak
molecular
mass
estim
comparison
protein
standard
pharmacia
run
column
protein
concentr
use
experi
mgml
protein
prepar
gelfiltrationpurifi
protein
dialys
crosslink
buffer
mm
hepe
ph
mm
nacl
concentr
mg
ml
ultrafiltr
kda
cutoff
protein
crosslink
ethyleneglycol
bi
succinimidylsuccin
eg
sigma
reaction
incub
h
ice
concentr
mm
mm
mm
mm
mm
eg
stop
mm
glycin
crosslink
product
analyz
reduc
condit
sdspage
polyacrylamid
gel
cd
spectra
perform
jasco
spectrophotomet
pb
mm
sodium
phosphat
ph
mm
nacl
wavelength
spectra
record
use
cm
pathlength
cuvett
thermodynam
stabil
measur
nm
record
cd
signal
temperatur
rang
scan
rate
deg
cmin
virusinduc
cell
fusion
assay
use
detect
fusion
inhibit
activ
design
protein
hela
cell
cultur
dulbecco
modifi
eagl
medium
dmem
gibco
contain
vv
fetal
calf
serum
fc
dilut
purifi
protein
sampl
dmem
without
fc
ad
cell
monolay
plate
time
adsorpt
ndv
strain
pfuwel
protein
use
neg
control
incub
h
inoculum
replac
dmem
fc
monolay
fix
stain
wv
crystal
violet
methanol
incub
h
co
incub
number
syncytia
well
count
reduct
syncytia
format
comparison
infect
cell
control
without
ad
protein
indic
fusioninhibit
activ
ndv
avirul
strain
clone
mediat
cell
fusion
assay
hela
cell
monolay
plate
infect
ndv
strain
clone
eid
h
infect
monolay
wash
three
time
dmem
digest
mgml
acetyl
trypsin
sigma
dmem
room
temperatur
min
follow
wash
three
time
mgml
trypsin
inhibitor
dmem
monolay
incub
dmem
contain
fc
anoth
h
stain
crystal
violet
detect
fusion
inhibit
abil
protein
sampl
ad
medium
viru
infect
trypsin
digest
digest
medium
contain
protein
sampl
replac
everi
h
fusioninhibit
activ
protein
sampl
evalu
describ
monolay
chicken
embryo
fibroblast
cell
prepar
accord
standard
method
dilut
purifi
protein
dmem
without
fc
ad
cell
monolay
sixwel
plate
time
adsorpt
ndv
strain
pfuwel
protein
use
neg
control
incub
h
inoculum
remov
monolay
overlaid
wv
white
agar
mix
equal
volum
dmem
contain
fc
plate
invert
incub
co
incub
h
stain
wv
neutral
red
pb
number
plaqu
well
count
plaqu
reduct
comparison
infect
cell
control
without
ad
protein
indic
inhibit
plaqu
format
